Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Jun 30, 2025. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 60
- +1 vs. Q1 2024
- Portfolio value
- $108.2M
- −$14.5M (−11.8%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CEROCero Therapeutics Holdings, Inc. | CLASS A COM | 12,972 | $3.88K | <0.1% | 00.0% | Unchanged | History |
| OMOutset Medical, Inc. | COM | 10,000 | $38.5K | <0.1% | +10,000 | New | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 16,000 | $65.4K | 0.1% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 28,800 | $66.5K | 0.1% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 17,833 | $68.7K | 0.1% | −2,000−10.1% | Reduced | History |
| CABACabaletta Bio, Inc. | COM | 10,000 | $74.8K | 0.1% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 50,000 | $87.0K | 0.1% | 00.0% | Unchanged | History |
| LQDALiquidia Corp | COM NEW | 10,000 | $120.0K | 0.1% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 138,176 | $124.5K | 0.1% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 12,110 | $170.6K | 0.2% | +12,110 | New | History |
| GTHXG1 Therapeutics, Inc. | COM | 80,000 | $182.4K | 0.2% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 40,000 | $199.6K | 0.2% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 12,300 | $232.8K | 0.2% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 40,000 | $247.2K | 0.2% | +20,000+100.0% | Added | History |
| BHVNBiohaven Ltd. | COM | 7,365 | $255.6K | 0.2% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 28,000 | $277.8K | 0.3% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 311,200 | $306.3K | 0.3% | −10,000−3.1% | Reduced | History |
| KROSKeros Therapeutics, Inc. | COM | 7,000 | $319.9K | 0.3% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 4,000 | $322.0K | 0.3% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 20,000 | $342.6K | 0.3% | +20,000 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 20,000 | $348.8K | 0.3% | −5,114−20.4% | Reduced | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 10,000 | $376.7K | 0.3% | 00.0% | Unchanged | History |
| AXDXAccelerate Diagnostics, Inc | COM | 325,239 | $380.5K | 0.4% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 10,000 | $389.9K | 0.4% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 2,500 | $395.0K | 0.4% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 15,000 | $399.3K | 0.4% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 469,832 | $407.6K | 0.4% | 00.0% | Unchanged | History |
| CHRSCoherus Oncology, Inc. | COM | 270,000 | $467.1K | 0.4% | 00.0% | Unchanged | History |
| HALOHalozyme Therapeutics, Inc. | COM | 10,000 | $523.6K | 0.5% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 14,000 | $537.0K | 0.5% | −4,000−22.2% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 10,000 | $541.8K | 0.5% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 46,000 | $541.9K | 0.5% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $560.1K | 0.5% | 00.0% | Unchanged | History |
| TXG10x Genomics, Inc. | CL A COM | 30,000 | $583.5K | 0.5% | 00.0% | Unchanged | History |
| PGNYProgyny, Inc. | COM | 22,000 | $629.4K | 0.6% | 00.0% | Unchanged | History |
| XOMExxonMobil Holdings Corp | COM | 5,849 | $673.3K | 0.6% | +5,849 | New | History |
| CSTLCastle Biosciences Inc | COM | 34,000 | $740.2K | 0.7% | +20,000+142.9% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 88,000 | $919.6K | 0.8% | 00.0% | Unchanged | History |
| TVTXTravere Therapeutics, Inc. | COM | 122,000 | $1.00M | 0.9% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.21M | 1.1% | 00.0% | Unchanged | History |
| DCGODocGo Inc. | COM | 460,000 | $1.42M | 1.3% | 00.0% | Unchanged | History |
| AXGNAxogen, Inc. | COM | 197,000 | $1.43M | 1.3% | +24,000+13.9% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 48,000 | $1.66M | 1.5% | 00.0% | Unchanged | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.73M | 1.6% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 320,930 | $1.85M | 1.7% | 00.0% | Unchanged | History |
| MASIMasimo Corp | COM | 15,280 | $1.92M | 1.8% | 00.0% | Unchanged | History |
| QDELQuidelOrtho Corp | COM | 67,619 | $2.25M | 2.1% | +2,416+3.7% | Added | History |
| CORTCorcept Therapeutics Inc | COM | 74,000 | $2.40M | 2.2% | +24,000+48.0% | Added | History |
| PHRPhreesia, Inc. | COM | 114,700 | $2.43M | 2.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 210,000 | $2.84M | 2.6% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 150,000 | $3.13M | 2.9% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 10,000 | $3.19M | 2.9% | −1,000−9.1% | Reduced | History |
| OVVOvintiv Inc. | COM | 74,200 | $3.48M | 3.2% | −10,000−11.9% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 250,400 | $4.07M | 3.8% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 203,574 | $4.20M | 3.9% | +34,000+20.1% | Added | History |
| SILKSilk Road Medical Inc | COM | 158,094 | $4.27M | 4.0% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 42,240 | $5.82M | 5.4% | −35,000−45.3% | Reduced | History |
| ELUTElutia Inc. | CL A COM | 1,551,655 | $7.70M | 7.1% | −103,529−6.3% | Reduced | History |
| BDSXBiodesix Inc | COM | 5,696,113 | $8.70M | 8.0% | +347,840+6.5% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 688,218 | $28.6M | 26.4% | −15,388−2.2% | Reduced | History |
Sold out since Q1 2024 (3)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | COM | 48,448 | $1.69M | 1.4% | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $997.5K | 0.8% | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,750 | $7.13K | <0.1% | History |